Doctor Ryoma Kani

Kameda Medical Center, Kamogawa (Japan)

Membership: ESC Professional Member

Follow

Contributor content

Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials

Presentation

Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis

Explore sponsored resources